Search research articles
Contact Us
Filters
Showing results (1-10 of 84) with videos related to
Page
of 9
Sort By:
European Journal of Pharmacology
|
August 28, 2019
Preface
Frank A Redegeld
Current Pharmaceutical Design
|
March 7, 2012
Editorial: modulation and new mediators in inflammation
Frank A Redegeld
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|
April 27, 2023
Mast cells-fetal mast cells crosstalk with maternal interfaces during pregnancy: Friend or foe?
Rasha Msallam, Frank A Redegeld
Current Opinion in Investigational Drugs (London, England : 2000)
|
October 28, 2008
IgE and immunoglobulin free light chains in allergic disease: new therapeutic opportunities
Frank A Redegeld, Cornelis H Wortel
Trends in Immunology
|
April 17, 2003
Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions?
Frank A Redegeld, Frans P Nijkamp
Clinical Reviews in Allergy & Immunology
|
July 1, 2019
Role of Mast Cells in Shaping the Tumor Microenvironment
Daniel Elieh Ali Komi, Frank A Redegeld
Current Pharmaceutical Design
|
June 13, 2009
Mast cells as target in cancer therapy
Tom Groot Kormelink, Abulikemu Abudukelimu, Frank A Redegeld
Mayo Clinic Proceedings
|
October 6, 2012
Polyclonal immunoglobulin free light chain and chronic inflammation
Frank A Redegeld, Marco Thio, Tom Groot Kormelink
Experimental Hematology
|
June 28, 2011
Toll-like receptor-9 triggering modulates expression of α-4 integrin on human B lymphocytes and their adhesion to extracellular matrix proteins
Jahangir Abdi, Ferdi Engels, Johan Garssen, et al.
Current Pharmaceutical Design
|
March 7, 2012
Immunobiology of antigen-specific immunoglobulin free light chains in chronic inflammatory diseases
Tom Groot Kormelink, Philip W Askenase, Frank A Redegeld
Page
of 9
Search research articles
Search
Showing results (1-10 of 84) with videos related to
Sort By:
Page
of 9
European Journal of Pharmacology
|
August 28, 2019
Preface
Frank A Redegeld
Current Pharmaceutical Design
|
March 7, 2012
Editorial: modulation and new mediators in inflammation
Frank A Redegeld
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|
April 27, 2023
Mast cells-fetal mast cells crosstalk with maternal interfaces during pregnancy: Friend or foe?
Rasha Msallam, Frank A Redegeld
Current Opinion in Investigational Drugs (London, England : 2000)
|
October 28, 2008
IgE and immunoglobulin free light chains in allergic disease: new therapeutic opportunities
Frank A Redegeld, Cornelis H Wortel
Trends in Immunology
|
April 17, 2003
Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions?
Frank A Redegeld, Frans P Nijkamp
Clinical Reviews in Allergy & Immunology
|
July 1, 2019
Role of Mast Cells in Shaping the Tumor Microenvironment
Daniel Elieh Ali Komi, Frank A Redegeld
Current Pharmaceutical Design
|
June 13, 2009
Mast cells as target in cancer therapy
Tom Groot Kormelink, Abulikemu Abudukelimu, Frank A Redegeld
Mayo Clinic Proceedings
|
October 6, 2012
Polyclonal immunoglobulin free light chain and chronic inflammation
Frank A Redegeld, Marco Thio, Tom Groot Kormelink
Experimental Hematology
|
June 28, 2011
Toll-like receptor-9 triggering modulates expression of α-4 integrin on human B lymphocytes and their adhesion to extracellular matrix proteins
Jahangir Abdi, Ferdi Engels, Johan Garssen, et al.
Current Pharmaceutical Design
|
March 7, 2012
Immunobiology of antigen-specific immunoglobulin free light chains in chronic inflammatory diseases
Tom Groot Kormelink, Philip W Askenase, Frank A Redegeld
Page
of 9